Upgrade to SI Premium - Free Trial

Oragenics (OGEN)

0.59 -0.01 (1.67%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form DEFA14A ORAGENICS INC May 20, 2026 4:11 PM - SEC Filing Form DEF 14A ORAGENICS INC For: May 20 May 20, 2026 4:06 PM - SEC Filing Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21 May 19, 2026 8:45 AM - Globe NewsWire Form 8-K ORAGENICS INC For: May 18 May 19, 2026 8:39 AM - SEC Filing Oragenics advances ONP-002 trial in Australia, signs device licensing deal May 18, 2026 8:31 AM - StreetInsider ORAGENICS PROVIDES INVESTOR UPDATE May 18, 2026 8:30 AM - Globe NewsWire Form PRE 14A ORAGENICS INC For: May 08 May 8, 2026 4:06 PM - SEC Filing Form 10-Q ORAGENICS INC For: Mar 31 May 8, 2026 4:02 PM - SEC Filing Oragenics signs letter of intent to license blood purification technology May 7, 2026 8:30 AM - StreetInsider Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation May 7, 2026 8:30 AM - Globe NewsWire Form 8-K ORAGENICS INC For: May 07 May 7, 2026 8:15 AM - SEC Filing Oragenics activates second site for ONP-002 brain injury trial May 5, 2026 8:31 AM - StreetInsider Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury. May 5, 2026 8:30 AM - Globe NewsWire Form 8-K ORAGENICS INC For: Apr 13 April 13, 2026 8:30 AM - SEC Filing Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury April 13, 2026 8:30 AM - Globe NewsWire Form 8-K ORAGENICS INC For: Mar 27 March 31, 2026 4:07 PM - SEC Filing Form EFFECT ORAGENICS INC March 23, 2026 6:07 AM - SEC Filing Form S-3/A ORAGENICS INC March 19, 2026 5:25 PM - SEC Filing Form 10-K ORAGENICS INC For: Dec 31 March 16, 2026 4:32 PM - SEC Filing Form 8-K ORAGENICS INC For: Mar 10 March 11, 2026 4:27 PM - SEC Filing Full Article List